后路融合术后应用重组人骨形态发生蛋白-2 微创减压并去除症状性异位骨形成
Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2.
机构信息
Section of Neurosurgery, Cleveland Clinic Indian River Hospital, Vero Beach, Florida, USA; Department of Neurosurgery, The George Washington University, Washington, DC, USA.
Section of Neurosurgery, Cleveland Clinic Indian River Hospital, Vero Beach, Florida, USA.
出版信息
World Neurosurg. 2020 Sep;141:430-436. doi: 10.1016/j.wneu.2020.04.235. Epub 2020 May 6.
Abstract
We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and "off-label" use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach.
摘要
我们报告了一例在翻修后路腰椎融合/内固定术及“超适应证”使用重组人骨形态发生蛋白-2后出现症状性异位骨形成的病例，采用微创管状入路治疗取得了成功。
Zotero 插件